新型驱动性改变非小细胞肺癌的生物药物:潜力和陷
Gianluca Russo1, Claudia Scimone1, Lucia Palumbo1
1Department of Public Health, University Federico II of Naples, Naples, Italy.
Critical reviews in oncology/hematology
|May 5, 2025
概括
精准医学通过分析瘤分子形状来推进肺癌治疗. 本综述强调了有希望的预测生物标志物,包括基于IHC的生物标志物,以改善患者分层和临床管理.
科学领域:
- 在瘤学瘤学.
- 分子诊断学 分子诊断
- 翻译医学是一种翻译医学.
背景情况:
- 精准医学通过瘤细胞的分子分析优化了肺癌 (LC) 治疗.
- 基因组学的进步导致了许多可用于临床使用的LC的预测生物标志物.
- 现有的强制性测试基因显示出临床益处,但需要新的生物标志物.
研究的目的:
- 审查非小细胞肺癌 (NSCLC) 患者有希望的预测生物标志物.
- 探索新兴生物标志物的整合到诊断面板中.
- 讨论多维"3D生物学"在LC患者分层中的作用.
主要方法:
- 对研究NSCLC预测生物标志物的临床试验的审查.
- 分析基因组,转录基因组和蛋白质基因组数据,以发现生物标志物.
- 评估基于免疫组织化学 (IHC) 的生物标志物作为整合性工具.
主要成果:
- 基因组和转录组数据对于识别预测生物标志物至关重要.
- 基于IHC的生物标志物显示了与现有诊断面板集成的潜力.
- 多维分析 (3D生物学) 是高级LC患者分层的关键.
结论:
- 新兴的生物标志物,包括基于IHC的生物标志物,对于推进LC临床管理至关重要.
- 整合不同类型的数据 (基因组,转录组,蛋白质组) 增强了患者的分层.
- 对新型生物标志物的持续研究对于优化NSCLC的精密医学至关重要.
更多相关视频
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Tumor Immunotherapy
401
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
401
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:49Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K